Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Glucotrack completes first-in-human continuous blood glucose monitor implant study
Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose monitor (CBGM). The study included participants with both type 1 and type 2 diabetes and began enrolling patients in early December 2024.
Glucotrack reports success in first human glucose monitor trial
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring system (CGM).
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (NASDAQ:GCTK) on Tuesday reported the successful completion of its first in human clinical study, sending shares up ~60% in the morning trade. This study represents first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein,
GlucoTrack announces completion of first in human clinical study of CGM
Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous
What did your breakfast just do to your blood sugar? Continuous glucose monitoring can ‘empower’ the diabetic and non-diabetic alike, experts say
Monitoring of the body's blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has long been a challenge, according to UW Medicines Diabetes Institute professor Irl Hirsch.
How tracking blood sugar with continuous glucose monitoring may be helpful
Some experts claim that reducing fluctuations throughout the day can help protect against heart disease, even for people who don't have diabetes.
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations often seen with traditional continuous glucose monitors that measure glucose levels in interstitial fluid.
6h
Does wearing a continuous glucose monitor help people without diabetes? We asked experts.
For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...
8d
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
10d
Is Blood Sugar Monitoring the Next Fitness Metric Everyone Needs?
Once reserved for people with diabetes, blood sugar monitors are now available over-the-counter. Two doctors explain what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
RFK Jr. clears Senate panel
Imposes tariffs on US goods
Pauses tariffs on Canada, MX
Antitrust violation probe
US, Philippines joint patrol
Southern border visit
3 children die in house fire
Accused attacker faces trial
'Special govt. employee'
2025 'Cowboy Carter' tour
Highway reopens after fires
MLB fires Pat Hoberg
Fund freeze block extended
Biden signs with CAA
To block Trump nominees
Suspended 10 games
Senate confirms Wright
Offers to jail US criminals
Sued for discrimination
Microplastics found in brains
‘Squid Game' actress dies
DOJ to battle antisemitism
EPA warns employees
FSU coach stepping down
Inks deal with SK’s Kakao
Stradivarius violin auction
Recall upgraded to Class I
Garrett requests trade
New York shields prescribers
Former Astros coach dies
Feedback